Abstract:BACKGROUND:Menin is a ubiquitously expressed protein encoded by the multiple endocrine neoplasia type 1 (MEN1) gene. Besides its importance in endocrine organs, menin has been shown to interact with the mixed lineage leukemia (MLL) protein, a histone H3 lysine 4 methyltransferase, and plays a critical role in hematopoiesis and leukemogenesis. Previous studies have shown that menin promotes transforming growth factor beta (TGF-β) signaling in endocrine cells. However, little is known regarding the impact of TGF-β pathway on menin in hematopoietic system. Here, with leukemia cell lines generated from conditional MEN1 or TGF-β receptor (TβRII) knockout mouse models, we investigated the possible cross-talk of these two pathways in leukemia cells.METHODS:MEN1 or TβRII conditional knockout mice were bred and the bone marrow cells were transduced with retroviruses expressing oncogeneic MLL-AF9 (a mixed lineage leukemia fusion protein) to generate two leukemia cell lines. Cell proliferation assays were performed to investigate the effect of TGF-β treatment on MLL-AF9 transformed leukemia cells with/without MEN1 or TβRII excision. Menin protein was detected with Western blotting and mRNA levels of cell proliferation-related genes Cyclin A(2) and Cyclin E(2) were examined with real-time RT-PCR for each treated sample. In vivo effect of TGF-β signal on menin expression was also investigated in mouse liver tissue after TβRII excision.RESULTS:TGF-β not only inhibited the proliferation of wild type MLL-AF9 transformed mouse bone marrow cells, but also up-regulated menin expression in these cells. Moreover, TGF-β failed to further inhibit the proliferation of Men1-null cells as compared to Men1-expressing control cells. Furthermore, excision of TβRII, a vital component in TGF-β signaling pathway, down-regulated menin expression in MLL-AF9 transformed mouse bone marrow cells. In vivo data also confirmed that menin expression was decreased in liver samples of conditional TβRII knockout mice after TβRII excision.CONCLUSION:These results provided the first piece of evidence of cross-talk between menin and TGF-β signaling pathways in regulating proliferation of leukemia cells, suggesting that manipulating the cross-talk of the two pathways may lead to a novel therapy for leukemia.

Progress on Biological Function of MEN 1 Gene

Menin in Cancer

Menin regulates endocrine diseases by controlling histone modification and gene transcription.

Menin Represses Malignant Phenotypes Of Melanoma Through Regulating Multiple Pathways

Menin Promotes Hepatocellular Carcinogenesis And Epigenetically Up-Regulates Yap1 Transcription

Functional Interaction Between Tumor Suppressor Menin And Activator Of S-Phase Kinase

Menin Epigenetically Represses Hedgehog Signaling in Men1 Tumor Syndrome

Menin Expression is Regulated by Transforming Growth Factor Beta Signaling in Leukemia Cells.

Applications of MEN1 gene and encoding protein thereof

A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology

Menin Enhances C-Myc-mediated Transcription to Promote Cancer Progression

A Novel Germline Mutation of the Men1 Gene Caused Multiple Endocrine Neoplasia Type 1 in A Chinese Young Man and 1 Year Follow-Up

Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas

Direct Binding of DNA by Tumor Suppressor Menin.

MEN1 Deficiency Leads to Neuroendocrine Differentiation of Lung Cancer and Disrupts the DNA Damage Response

MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer

MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation

Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin.

Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene

Supplementary Figures 1-7 from Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome

Menin signaling and therapeutic targeting in breast cancer